The scope of mycoplasma contamination within the biopharmaceutical industry

Biologicals

Volumn 38, Issue 2, 2010, Pages 211-213

  Armstrong, Shayn E ^a   Mariano, Jill A ^a   Lundin, Daniel J ^a  

^a Bionique Testing Laboratories Inc   (United States)

Author keywords

Biologicals; Cell cultures; Mycoplasma contamination; Prevalence; Rapid microbiological methods

Indexed keywords

ANALYTIC METHOD; ARTICLE; BACTERIUM CONTAMINATION; BACTERIUM DETECTION; CELL CULTURE; CONTROLLED STUDY; DRUG INDUSTRY; MYCOPLASMA; MYCOPLASMOSIS; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; BIOLOGICAL PRODUCTS; BIOPHARMACEUTICS; CELLS, CULTURED; COHORT STUDIES; CULTURE MEDIA; DNA, BACTERIAL; DRUG CONTAMINATION; DRUG INDUSTRY; FLUORESCENCE; HUMANS; MANUFACTURED MATERIALS; MICROBIOLOGICAL TECHNIQUES; MYCOPLASMA; MYCOPLASMA INFECTIONS; RETROSPECTIVE STUDIES;

MYCOPLASMA;

EID: 77950646341     PISSN: 10451056     EISSN: 10958320     Source Type: Journal    
DOI: 10.1016/j.biologicals.2010.03.002     Document Type: Article

References (7)

1. Robinson L.B., Wichelhausen R.H., Roizman B. Contamination of human cell cultures by pleuropneumonialike organisms. Science 1956, 224:1147-1148.
2. Drexler H.G., Uphoff C.C. Mycoplasma contamination of cell cultures: incidence, sources, effect, detection, elimination, prevention. Cytotechnology 2002, 39:75-90.
3. CBER, FDA Points to consider in the characterization of cell lines used to produce biologicals Attachment #2 - recommended procedures for detection of mycoplasma contamination in biological products in cell substrates. Available at:. http://www.fda.gov/cber/gdlns/ptccell.pdf.
4. American Guideline 21 CFR 610.30 Code of Federal Regulations 21 CFR Ch. 1 (4/4/01 edition) § 610.30 Subpart D-mycoplasma Available at:. http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm%3FFR%3D610.30.
5. Mycoplasmas 2.6.7. European Pharmacopoeia (PhEur) 6.0 2007, vol. 1. Council of Europe, Strasboug, France, p. 159-64.
6. Mycoplasma testing for cell substrates used for the production of biotechnological/biological products. Japanese Pharmacopoeia Fifteenth Edition 2006, 1721-1724.
7. Barile M.F., Kern J. Isolation of Mycoplasma arginini from commercial bovine sera and its implication in contaminated cell cultures. Proc Soc Exp Biol Med 1971, 138:432-437.